an ethically approved prospective study conducted at a tertiary referral endocrine center in the UK. Intra-operative outcome measures included procedure time and blood loss. Postoperative measures included biochemical and histopathological assessment. Patient-reported outcome measures (PROMS) included subjective assessment of pain and scar cosmesis using Visual analogue scores, Voice Disability Index 2 and EQ5 HD quality of life assessment recorded 1 day, 2 weeks, 3 and 6 months postoperatively. RESULTS: In all cases the parathyroid adenoma was successfully identified and removed. Blood loss was negligible (Ͻ5 ml). The recurrent laryngeal nerve (RLN) was identified and preserved in all cases. Mean robot docking and closure times plateaued to 19 minutes and 24 minutes respectively. The mean robotic console time was 65 minutes (range 25-105 minutes). Factors determining the console time were body habitus, size of the parathyroid adenoma and surgical access. Postoperative pain was minimal in the post-op period and disappeared thereafter. Subjective voice assessment showed no change in voice quality. All EQ5 HD quality of life parameters significantly improved (pϽ0.05). Patients were discharged on the 1st post operative day. Mean time to return to daily activities was 3.4 days. CONCLUSION: Robotic assisted parathyroidectomy represents a novel targeted "scar-less in the neck" surgical approach. Preliminary results suggest improved patient satisfaction, minimal postoperative pain and rapid return to daily activities.
OBJECTIVE: 1) Determine test performance of sentinel node biopsy (SNB) in head and neck (H&N) melanoma. 2) Calculate SNB identification and false negative rate. METHOD: A systematic literature review of studies between 1990-2009 was performed. Dual blind data extraction was conducted. Primary outcomes included identification rates and test performance based on completion neck dissection (CND) or nodal recurrence. RESULTS: Eligibility criteria were met for 32 studies (2,694 patients). Enrollment varied from 9 to 629 patients (median 55). Mean Breslow was 2.53 mm (range 0.02 mm to 20 mm). The median SNB identification rate was 95.7% (range 12% to 100%). More than 1 basin was reported in 33.1% of patients. A median of 2.56 sentinel nodes per patient were excised. In 17.1% of patients, SNB were positive. Additional positive nodes were found in 22.5% of patients that underwent CND. Median follow-up time was 30 months (range 1 to 125). Among patients with negative SNB, recurrent disease was reported in 12%, including 2.2% in the nodal basin. The false negative rate for nodal recurrence was reported in 24 studies with a median 10.7%. Among patients with a positive SNB, recurrent disease was reported in 62.5%, including 14.1% in the nodal basin. CONCLUSION: SNB of H&N melanoma has an identification rate of 95.7% with 10.7% false negative rate and is comparable to SNB of non-H&N melanoma. However, unique aspects of SNB for H&N melanoma include 33.1% of patients have sentinel nodes in multiple basins and 62.5% of patients with positive SNB experience tumor recurrence.
Sentinel Node Biopsy in Thyroid Cancer: Does it Work? Sumeet Anand, MSc, MD (presenter); Richard Payne, MD; Olga Gologan, MD; Louise Rochon, MD OBJECTIVE: To prospectively review the role of sentinel lymph node (SLN) biopsy in the management of well differentiated thyroid carcinoma (WDTC), and determine whether frozen section analysis accurately predicts the status of the SLN. Our study assesses, first, whether specific lymph nodes (SLN) consistently receive malignant cells from a thyroid carcinoma and, second, whether a negative SLN on frozen section reliably predicts a disease-free central compartment. METHOD: SLN biopsy was performed on consecutive patients undergoing thyroidectomy at the McGill University Thyroid Cancer Center in Montreal, Canada. Nodules were injected with 0.3ccs of methylene blue. A central compartment neck dissection was performed. Lymph nodes that stained blue were considered as SLNs. Frozen section analysis of the SLNs was performed. RESULTS: 237 patients underwent SLN biopsy and central compartment neck dissection. 103 patients had WDTC. 75% (77/103) of patients were found to have detectable SLNs. No patients (0/26) with undetectable SLNs were found to have central compartment metastasis. 29% (22 of 77) of patients had positive SLNs for metastasis. A negative SLN corresponded with a negative central compartment 98% of the time (54/55, sensitivity 98%, p-value Ͻ0.05). Frozen section was able to detect metastasis in 91% (10/11) of patients' SLNs. CONCLUSION: Our data shows that a negative SLN on final pathology correlates strongly with a negative central compartment. Frozen section is an accurate method to determine the status of the SLN. This series shows that if a patient has benign SLNs, a central compartment neck dissection can be spared. 
